Spherix Incorporated Rodman, Dr. Claire Kruger, CEO, and Dr. Robert Lodder, President, announces that they will present a corporate overview at the Rodman & Renshaw 11(th) Annual Healthcare Conference on September 11, 2009 at New York Palace Hotel in New York City. StockEinstein.com offers free trading alerts on stocks about to run. To sign up for our free alert service please click here www.stockeinstein.com or scroll to bottom of this page to sign up.
Spherix Incorporated, together with its subsidiaries, operates as a scientific research company. The company develops products for the treatment for Type 2 diabetes. Its product pipeline includes Naturlose, which is in Phase III clinical trials for the treatment of Type 2 diabetes. The company also provides technical and regulatory consulting services to biotechnology and pharmaceutical companies. Spherix Incorporated was founded in 1967 and is headquartered in Bethesda, Maryland.
About StockEinstein
StockEinstein.com uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
Thank you for your interest in Findit News. A member of the Findit News team will contact you soon to show you how you can take your marketing to the next level with press releases on Findit.
